ES2139568T3 - Complejo proteico. - Google Patents

Complejo proteico.

Info

Publication number
ES2139568T3
ES2139568T3 ES90906389T ES90906389T ES2139568T3 ES 2139568 T3 ES2139568 T3 ES 2139568T3 ES 90906389 T ES90906389 T ES 90906389T ES 90906389 T ES90906389 T ES 90906389T ES 2139568 T3 ES2139568 T3 ES 2139568T3
Authority
ES
Spain
Prior art keywords
macromolecule
protein complex
sperm
assay
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906389T
Other languages
English (en)
Inventor
Eva Akerlof
Ake Pousette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2139568T3 publication Critical patent/ES2139568T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA MACROMOLECULA DE NATURALEZA PROTEINICA QUE ACTIVA LA MOVILIDAD ESPERMATICA, UN PROCESO PARA LA PREPARACION DE LA MISMA MEDIANTE PURIFICACION DE LA MACROMOLECULA DE FLUIDOS EXTRACELULARES, PREPARACIONES FARMACEUTICAS QUE CONSTAN DE LA MACROMOLECULA Y ANTICUERPOS DIRIGIDOS CONTRA ESPECIFICOS DETERMINANTES A DICHA MACROMOLECULA Y LA UTILIZACION DE LA MISMA ASI COMO UN METODO PARA ENSAYAR LA FERTILIDAD POTENCIAL DEL ESPERMA.
ES90906389T 1989-03-31 1990-04-02 Complejo proteico. Expired - Lifetime ES2139568T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901127A SE8901127D0 (sv) 1989-03-31 1989-03-31 Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras

Publications (1)

Publication Number Publication Date
ES2139568T3 true ES2139568T3 (es) 2000-02-16

Family

ID=20375510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906389T Expired - Lifetime ES2139568T3 (es) 1989-03-31 1990-04-02 Complejo proteico.

Country Status (10)

Country Link
US (2) US5304464A (es)
EP (2) EP0965595A1 (es)
JP (1) JP2886979B2 (es)
AT (1) ATE185150T1 (es)
AU (1) AU635258B2 (es)
DE (1) DE69033306T2 (es)
DK (1) DK0474645T3 (es)
ES (1) ES2139568T3 (es)
SE (1) SE8901127D0 (es)
WO (1) WO1990012032A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE132269T1 (de) * 1990-11-30 1996-01-15 Monoclonetics Int Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
AU734337B2 (en) * 1996-11-21 2001-06-14 Promega Corporation Alkyl peptide amides and applications
EP0939085A1 (en) * 1998-02-26 1999-09-01 Council of Scientific and Industrial Research A process for the purification of a motility-promoting protein from buffalo serum
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
EP2997823B1 (en) 2014-09-19 2017-12-20 Instruments Utils de Laboratori Geniul, SL Procedure to improve sperm quality in mammals
CN107998397B (zh) * 2017-12-07 2020-09-04 复旦大学附属华山医院 Emc10蛋白作为生物标志物在诊断男性不育中的应用
JP7360008B2 (ja) 2019-03-22 2023-10-12 日亜化学工業株式会社 精子の運動能力を増加させる方法及び装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339434A (en) * 1981-08-17 1982-07-13 Gametrics Limited Method of increasing the incidence of female offspring
US4511558A (en) * 1983-05-16 1985-04-16 University Patents, Inc. Alpha-lactalbumin contraceptive
SE449003B (sv) * 1985-10-18 1987-03-30 Pharmacia Ab Sett att in vitro avskilja spermier med egen rorelseformaga medelst penetrationsmedium i vilket ingar hyaluronsyrasalt
US4765972A (en) * 1986-04-03 1988-08-23 The United States Of America As Represented By The Department Of Health And Human Services Vinca alkaloid photoactive analogs and their uses
US5059680A (en) * 1986-11-24 1991-10-22 Centocor, Inc. Method of isolating ca 125 antigen
US5166190A (en) * 1990-01-08 1992-11-24 Genentech, Inc. Method for increasing fertility in males

Also Published As

Publication number Publication date
EP0965595A1 (en) 1999-12-22
US5304464A (en) 1994-04-19
JPH04505614A (ja) 1992-10-01
ATE185150T1 (de) 1999-10-15
DK0474645T3 (da) 2000-03-27
EP0474645A1 (en) 1992-03-18
SE8901127D0 (sv) 1989-03-31
DE69033306D1 (de) 1999-11-04
EP0474645B1 (en) 1999-09-29
WO1990012032A1 (en) 1990-10-18
AU5431890A (en) 1990-11-05
JP2886979B2 (ja) 1999-04-26
AU635258B2 (en) 1993-03-18
DE69033306T2 (de) 2000-04-13
US5453354A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
YU49370B (sh) Postupak za pripremanje vakcine protiv lajmske bolesti
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO961115D0 (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
EP0683234A4 (en) ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE.
ATE150319T1 (de) Behandlung von asthma
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE148708T1 (de) Verfahren zur reinigung von waessrigen extrakten, die allergenische proteine enthalten, so erhaltene extrakte und ihre verwendung
DK0474645T3 (da) Proteinkompleks
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
DE69311796T2 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
DK0489771T3 (da) Modificerede humane anti-Rh(D)-antistoffer
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
DK438883D0 (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmade til fremstilling heraf
PT85248A (fr) Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
ATE328088T1 (de) Transketolase-verwandtes protein
ES2076238T3 (es) Adnc que codifica la proteina 9 de placenta (pp9), su aislamiento y utilizacion.
FR2663748B1 (fr) Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
IT8921396A0 (it) Procedimento per la sintesi di peptidi preventivamente identificati come siti di interazione di proteine interagenti.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 474645

Country of ref document: ES